Deepa Gotur, MD
Critical Care Medicine · Houston, TXNPI 1063671600
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,388 of the $22,914 with a category attached, or 93.3%. GSK accounts for 70.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $16,675 and has fallen 98.5% since, to $258 in 2024. Among critical care medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $739.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$16K
- Modernatx, Inc.$5K
- AstraZeneca$305
- Boehringer Ingelheim$160
- La Jolla Pharmaceutical Company$157
- Edwards Lifesciences$149
- plus $569 from 8 others
Across 40 payments — averaging $27,851 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rigel Pharmaceuticals, Inc.$563K
- Hoffmann-la Roche Limited$456K
- AstraZeneca$55K
- Gilead$40K
- F. Hoffmann-la Roche AG$853
What the payments were for
- Consulting fees$21,38893%
- Travel & lodging$1741%
- Food & beverage$1,3526%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 3 | $16,250 |
| Modernatx, Inc. | 3 | $5,323 |
| AstraZeneca | 3 | $305 |
| Boehringer Ingelheim | 3 | $160 |
| La Jolla Pharmaceutical Company | 3 | $157 |
| Edwards Lifesciences | 1 | $149 |
| Actelion Pharmaceuticals US, Inc. | 1 | $145 |
| AbbVie | 7 | $139 |
| Dova Pharmaceuticals | 1 | $112 |
| Shionogi Inc | 2 | $50 |
| Abbott | 1 | $50 |
| Johnson & Johnson | 1 | $34 |
| Grifols USA, LLC | 1 | $21 |
| Pharming Healthcare, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Moderna Covid-19 Vaccine$5,312
- HemoSphere$149
- OPSUMIT$145
- UPTRAVI$145
- LOKELMA$123
- DOPTELET$112
How this compares
$22,914 in reported general payments places this provider in the 90th percentile of 507 critical care medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Houston
- Edwin ParsleyHouston$283K
- Bindu AkkantiHouston$185K
- Faisal MasudHouston$155K
- Sergio Trevino CastilloHouston$133K
- Sami HossriHouston$34K
- George WilliamsHouston$33K
- Nicholas VillalobosHouston$26K
- Ranjan UpadhyayHouston$25K
- Hany Abd-El MalekHouston$19K
- Kha DinhHouston$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.